IN THE MANAGEMENT OF

ELEVATED INTRACRANIAL PRESSURE (ICP)

Missing the full picture with your

current monitoring system?

From ICP to
IC More.
CereLink™ System provides uncompromised
advanced continuous ICP monitoring—with
minimal drift, MR conditional capability,
durable, flexible ICP sensors, and
advanced data presentation features.1,2

CereLinkICP monitoring system

TM

Discover the Unseen

A D I V I S I O N O F I N T EG R A L I F E S C I E N C E S integralife.com
Uncompromised
ICP Monitoring.
See More…
More Accuracy More Protection
Due To Less Drift1-3 MR Conditional Capability
The CereLink System is more accurate Features 1.5 and 3T MR conditional
than the leading competitor in terms capability for all sensor configurations
of less drift over time1-3

CereLink vs Camino Drift Over Time

6
Camino Max
5
CereLink Max
4
CereLink Average
± mmHg

3
2
1
0
0 5 7 14 21 30 Days

Camino Data not available after 5 days. Camino average drift not available.

A D I V I S I O N O F I N T EG R A L I F E S C I E N C E S
 CereLink ICP monitoring system
TM

More Choice More Information

Durable, Flexible ICP Sensors Advanced Data Presentation
Sensor flexibility allows for physician Time Above Threshold and Histograms

choice in implantation and fixation

methods with greater durability

Pressure Time Dosage

CereLink TM

ICP monitoring system

Discover the Unseen

integralife.com
From ICP to IC More.
CereLink™ System provides:
• The CereLink System is more accurate than the leading
competitor in terms of less drift over time1-3
• MR conditional capability
• Durable, flexible ICP sensors
826820
• Advanced data presentation features CereLink ICP Monitor

Ordering Information
SKU Description
826820 CereLink ICP Monitor
Box
826845 CereLink ICP Extension Cable
826850 CereLink ICP Sensor Basic Kit
CereLink 826851 CereLink ICP Metal Bolt Kit 826850
ICP Sensors CereLink ICP Sensor Basic Kit
826852 CereLink ICP Plastic Bolt Kit
826854 CereLink ICP Ventricular Kit
826880 DRAGER / SIEMENS Infinity 826854
CereLink ICP Ventricular Kit
826881 PHILIPS Intellivue
826882 GE Dash
Patient 826883 SPACELABS 6-pin
Monitor Cables 826884 GE Datex Ohmeda
826851
826887 NIHON KODEN 5-pin CereLink ICP Metal Bolt Kit
826888 FUKUDA DENSHI DS-800
826889 FUKUDA DENSHI DS-7000
826822 CereLink ICP Monitor Replacement Power Supply See more at
Accessories 826824
EXPORTCAB
CereLink ICP Monitor Replacement Battery
CereLink USB to RS232 Adapter
www.nocompromiseICP.com
References: 1. Camino® system IFU (A40256 Rev H) and CereLink system IFUs. 2. Crutchfield JS, Narayan RK, Robertson CS, Michael LH. Evaluation of a fiberoptic intracranial pressure monitor. J Neurosurg. 1990;72(3):482-487.
3. Camino® IFU data states max drift ±6 mmHg over 5 days; CereLink bench test shows max (2 stdev) of ±2.2 mmHg over 7 days.
Consult the Instructions for Use for complete indications, warnings and precautions.
826820 Indications for Use • The ICP Monitor is intended for use as an interface between compatible strain gauge type pressure transducers and standard physiological pressure monitoring systems. The ICP Monitor is also
intended for use as an independent pressure monitor for displaying the mean, systolic and diastolic values of a physiologic pressure waveform in the absence of an external patient monitor. Contraindications • The ICP Monitor is
contraindicated for use in a Magnetic Resonance (MR) environment. Refer to the ICP Sensor IFU for MR environment use. Precautions • Exposure to electrostatic discharge (ESD) energy could damage the ICP Sensor connected to
this device. Please refer to the ICP Sensor IFU for more information. • The signal processing algorithms used to detect and display physiological pressure data may vary among patient bedside monitors of different make and model.
Therefore, pressure data displayed by the ICP Monitor may not always be consistent with the data displayed on an externally connected patient bedside monitor. Refer to the patient bedside monitor manufacturer’s instruction
manual for specific details regarding signal processing, calibration and accuracy. • The ICP Sensor is susceptible to defibrillator or electrosurgical equipment voltages and could lead to permanent or temporary disabling of the
sensor. The sensor may need to be replaced before ICP monitoring can resume. 826850, 826851, 826852, 826854 Indications for Use • (826850, 826851, 826852) Use of the CereLink ICP Sensor Basic Kit and CereLink ICP Bolt Kit are
indicated when direct intracranial pressure (ICP) monitoring is required. The kit is indicated for use in both subdural and intraparenchymal pressure monitoring applications only. •(826854) Use of the CereLink ICP Ventricular Kit is
indicated when direct intracranial pressure (ICP) monitoring is required. The kit is indicated for use in intraventricular pressure monitoring and cerebral spinal fluid (CSF) drainage applications. Contraindications • This kit is not
designed, sold or intended for use as a therapeutic device (826850-826852 only) • Ventriculostomy is contraindicated in patients with coagulopathy or active infection in the area of the catheter. •Use of the Ventricular Catheter Kit
is contraindicated in children less than one year of age. • Insertion of the skull bolt is contraindicated in children less than one year of age. Warnings • Take extreme care to avoid damage to the dura and underlying cerebrum. • The
use of electrosurgical equipment, e.g., monopolar, bipolar, diathermy, can cause damage to the CereLink Sensor and/or the ICP Monitor. This could lead to permanent or temporary disabling of either device. • Before conducting an
MRI procedure on a patient with an implanted CereLink Sensor, read the MRI Information section of the IFU. Failure to read and strictly adhere to these guidelines can result in serious injury to the patient. • Installation of the skull
bolt must be performed with the bolt held within 10 degrees of the perpendicular to the incision site. Installing at an angle can result in fracture of the device or in an inadequate seal between the washer and the skull. • Do not
remove the thrust washer or the sealing washer that are preassembled on the skull bolt, as this can result in an inadequate seal between the washer and the skull. • Excessive torque applied to the skull bolt during insertion can cause
breakage. This device is designed to break off at the area between the hexagonals, if excessive torque is applied. The lower portion of the screw can then be removed, using the screw handle. Precautions • Avoid direct contact with
the sensing element at the transducer tip. Care must be taken at all times during handling of the transducer to protect the tip from impact. Damage could result. • Exposure to electrostatic discharge (ESD) energy could damage this
device. High levels of ESD could damage the electronic components and cause the transducer to be rendered inaccurate or inoperable. Take all precautions to reduce the buildup of electrostatic charge during the use of this product
and avoid touching the transducer connector pins, which are identified with the ESD symbol. (Refer to Electrostatic Discharge (ESD) Information section of the IFU.) • Do not forcibly pull or jerk the transducer catheter. Excessive
force can result in fracture of the transducer of unintended withdrawal from the skull bolt. • Silicone is highly electrostatic and, as a result, attracts airborne particles and surface contaminants that could produce tissue reaction.
Use extreme care to prevent the ventricular catheter from coming in contact with towels, drapes, talc, or any other linty or granular surface, as well as airborne particles. • Silicone has a low cut and tear resistance; therefore, care
should be exercised when placing ligatures so as not to tie them too tightly. The use of stainless steel ligatures on silicone is not advised. In addition, tying sutures too tightly can collapse the wall of the sensor body, causing damage
to internal wires. Adverse Events • The following Adverse Events may occur with the use of the CereLink ICP Sensor: • Hemorrhage* • Infection • Subcutaneous CSF leakage • Neurological sequelae *Subarachnoid, intracerebral, or
extracerebral hemorrhage may occur at the site of transducer placement (either skull, cortical, or dural areas). Testing of the blood clotting factor should be conducted on patients before insertion.

Availability of these products might vary from a given country or region to another, as a result of specific local regulatory approval or clearance requirements for sale in such country or region.
nNon contractual document. The manufacturer reserves the right, without prior notice, to modify the products in order to improve their quality.
nWarning: Applicable laws restrict these products to sale by or on the order of a physician.
nConsult product labels and inserts for any indication, contraindications, hazards, warnings, precautions, and instructions for use.

For more information or to place an order, please contact:

United States, Canada, Asia, Pacific, Latin America
USA 800-654-2873 888-980-7742 fax
n

International +1 609-936-5400 +1 609-750-4259 fax n

integralife.com
Codman, Integra, and the Integra logo are registered trademarks of Integra LifeSciences Corporation or its subsidiaries in the United States and/or other countries. CereLink is a trademark of
Integra LifeSciences Corporation or its subsidiaries. Camino is a registered trademark of Natus Medical Inc. All other trademarks and trade names are the property of their respective owners.
©2019 Integra LifeSciences Corporation. All rights reserved. 1226701-3-EN